An unknown buyer cancelled the acquisition of 2.40% stake in CrystalGenomics, Inc. from Kumho HT, Inc.
December 13, 2023
Share
An unknown buyer agreed to acquire approximately 2.40% stake in CrystalGenomics, Inc. (KOSDAQ:A083790) from Kumho HT, Inc (KOSE:A214330) for KRW 28 billion on March 30, 2023. The consideration comprises of down payment of KRW 2.80 billion, interim payment of KRW 2.80 billion on April 30, 2023, and balance payment of KRW 22.40 billion on June 30, 2023. After this disposal, Kumho?s ownership will decrease to 3.833 million shares, representing approximately 5.10% stake in CrystalGenomics. The transaction is expected to close on June 30, 2023.
An unknown buyer cancelled the acquisition of 2.40% stake in CrystalGenomics, Inc. (KOSDAQ:A083790) from Kumho HT, Inc (KOSE:A214330) on December 14, 2023.
CG Invites Co Ltd is a Korea-based company principally engaged in the development and manufacturing of pharmaceuticals. The Company operates its business through three segments. The Pharmaceutical Research and Development segment is engaged in the research, development and sale of new drugs such as anti-inflammatory painkillers, anticancer drugs, anti-infectives and others. It is also engaged in the real estate rental business. The Pharmaceutical Manufacturing segment is engaged in the manufacture, retail and wholesale of finished drug products. The Other segment is engaged in the manufacture and sale of hot packs and other household items.
CRYSTALGENOMICS INVITES CO., LTD. 
